HISTOGENEX
HistoGeneX Laboratories is a privately held service provider of biomarker technologies for translational and clinical research and is a CAP, CLIA and BELAC-accredited laboratory. With facilities located in Antwerp, Belgium and Chicago, Illinois, and taking steps to establish a site in China, HistoGeneX provides a networked footprint for global clinical trials. Our services and products stem from a pathology and patient care perspective. We are experts at handling all human biological specimens and deploy the relevant technologies to extract the valuable information contained within for research and diagnostic applications.
HISTOGENEX
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2001-01-01
Address:
Antwerp, Antwerpen, Belgium
Country:
Belgium
Website Url:
http://www.histogenex.com
Total Employee:
101+
Status:
Active
Contact:
+32 3 218 10 80
Total Funding:
0
Technology used in webpage:
SPF Apple Mobile Web Clips Icon Domain Not Resolving Mobile Non Scaleable Content Microsoft Exchange Online Office 365 Mail ReCAPTCHA Sectigo SSL ReCAPTCHA V2 Sectigo Domain SSL
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
PCI Pharma Services
PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.
Current Employees Featured
Founder
Investors List
Waterland Private Equity
Waterland Private Equity investment in Private Equity Round - HistoGeneX
Official Site Inspections
http://www.histogenex.com
- Host name: hosting13.parkour3.com
- IP address: 159.89.115.187
- Location: Toronto Canada
- Latitude: 43.6547
- Longitude: -79.3623
- Timezone: America/Toronto
- Postal: M5A
More informations about "HistoGeneX"
HistoGeneX - Crunchbase Company Profile & Funding
HistoGeneX Laboratories is a privately held service provider of biomarker technologies for translational and clinical research and is a CAP, CLIA and …See details»
About us - CellCarta
Mr. Ung leads the development and execution of HistoGeneX’s strategic and business initiatives, leveraging the company’s solid tumor and anatomic pathology services. Prior to joining …See details»
Caprion-HistoGeneX Unites as CellCarta- Precision …
Jan 26, 2021 Precision Medicine Leader Caprion-HistoGeneX Rebrands as CellCarta. MONTREAL, Canada, January 26, 2021 – Caprion-HistoGeneX, a leading global provider of specialized precision medicine laboratory services …See details»
CellCarta | A Global Contract Research Organization
Mar 17, 2025 Discover CellCarta's precision medicine testing services. Explore immunology, histopathology, proteomics, genomics, and digital pathology.See details»
Precision Medicine Leader Caprion-HistoGeneX Rebrands as …
The new name for the Montreal-headquartered company stems from the 2019 combination of contract research organization Caprion Biosciences, which specializes in immunology and …See details»
Precision Medicine Leader Caprion-HistoGeneX Rebrands as
MONTREAL, Jan. 26, 2021 /CNW/ - Caprion-HistoGeneX, a leading global provider of specialized precision medicine laboratory services to the biopharmaceutical industry, is pleased to …See details»
HistoGeneX - Waterland
HistoGeneX, a laboratory group established in 2001, supports pharmaceutical and biotechnology companies in the process of developing, approving and monitoring new anticancer drugs …See details»
HistoGeneX - Funding, Financials, Valuation & Investors
Jan 25, 2016 HistoGeneX is provider of biomarker technologies for translational and clinical research and is a CAP, CLIA and BELAC-accredited laboratory. New. Resources. ... How …See details»
CellCarta Company Profile - Office Locations, Competitors ... - Craft
CellCarta (formerly known as HistoGeneX) is a service provider of biomarker technologies for translational and clinical research and is a CAP, CLIA, and BELAC-accredited laboratory. It …See details»
Caprion and HistoGeneX Merge to Lead Global Immune …
Jul 31, 2019 Caprion Biosciences and HistoGeneX Unite Businesses to Create Global Leader in Immune Monitoring and Biomarker Development. Partnership Facilitated by Major Investment …See details»
Caprion acquires HistoGeneX - 2019-08-01 - Crunchbase
Aug 1, 2019 HistoGeneX HistoGeneX is provider of biomarker technologies for translational and clinical research and is a CAP, CLIA and BELAC-accredited laboratory. Acquiring …See details»
HistoGeneX - Company Profile - BizStanding
Company Profile. Industry: Biotechnology Site: histogenex.com Description: AT HISTOGENEX, WE TAKE PRIDE IN BRIDGING TECHNOLOGIES, EXPERTISE AND EXPERIENCE. Our …See details»
HistoGeneX - VentureRadar
HistoGeneX is involved since 2003 in several oncology trials and is responsible for tissue biomarker development, validation and GLP/GCP testing/cancer profiling. * TAGS : Life …See details»
HistoGeneX - Contacts, Employees, Board Members, Advisors
HistoGeneX is provider of biomarker technologies for translational and clinical research and is a CAP, CLIA and BELAC-accredited laboratory. ... Experience the new Crunchbase, powered by …See details»
Caprion Biosciences et HistoGeneX regroupent leurs activités
Jul 31, 2019 Caprion et HistoGeneX continueront de fournir leurs solutions et services actuels à leurs clients, toujours selon leurs normes élevées de qualité et d’expertise scientifique. Au …See details»
HistoGeneX - Products, Competitors, Financials, Employees, …
HistoGeneX supports pharmaceutical and biotechnology companies in the process of developing, approving and monitoring new cancer drugs by developing and carrying out biomarker tests. …See details»
Histogenex - Scientist.com
Histogenex N.V. Sint-Bavostraat 78-80 Wilrijk, Antwerpen, 2610 Belgium: Histogenex 1331 West 75th Street Suite 401 Naperville, IL, 60540 United States: Get started If your organization has …See details»
Caprion-HistoGeneX is now CellCarta
Jan 26, 2021 Our Singular Vision has a Bold New Name – CellCarta. CellCarta brings together (January 26, 2021) two leading contract research organizations in biomarker services: Caprion …See details»
Caprion Biosciences and HistoGeneX Unite Businesses to
Jul 31, 2019 /CNW/ -- Caprion Biosciences ("Caprion") and HistoGeneX announced today they have agreed to combine their respective businesses. The new partnership creates a...See details»
Caprion-HistoGeneX acquires - CellCarta
Jan 7, 2021 Caprion-HistoGeneX is a leading provider of specialized precision medicine laboratory services to the biopharmaceutical industry. Leveraging its integrated analytical …See details»